Nike, Synaptics, Edwards Lifesciences, AsiaStrategy and Mangoceuticals were among the stocks drawing investor attention Friday as U.S. stock futures traded higher. Nike reported first-quarter revenue of $11.21 billion, below the $11.33 billion analyst estimate, while adjusted earnings of 48 cents per share topped expectations of 44 cents. Its shares fell 8.7% to $32.09 in after-hours trading. Synaptics climbed 15% to $122.10 after announcing that ON Semiconductor will acquire it for $123 per share under a revised agreement. Edwards Lifesciences said the FDA (U.S. drug regulator) approved its AUTUS valve, the first surgical pulmonary valve for pediatric patients; Edwards shares fell 1.3% to close at $85.19 Thursday. AsiaStrategy rose 30.8% to $3.07 after disclosing a non-binding memorandum of understanding with Plume to advance real-world asset tokenization (turning physical assets into blockchain-based tokens) across Asia. Mangoceuticals dropped 12.2% to $0.42 after saying its former subsidiary secured a $2.5 million strategic investment.